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Purpose or Objective: To assess the dosimetric accuracy of CT-substitute attenuation correction (AC) maps generated from existent clinical MR data for radiation treatment planning in glioma patients.
Material and Methods:
CT substitute AC maps were obtained with Statistical Parametric Software (SPM) software applied on 3D T1-weighted Inversion Recovery scans (IT 650 ms; TR/TE 4.6/2.0 ms). Three probability maps (PM) were obtained: air, tissue and bone. To derive corresponding AC maps, air-PM was multiplied by -1000, tissue-PM by 30 and bone-PM by 1000 and 300 when the probability for bone tissue was >0.8 and <0.8, respectively. A composite AC map (MR-based CT) was obtained by summing up all the PM multiplied by the aforementioned values. Difference in bone between clinical CT and MR-based CT was quantified with the Dice Similarity Coefficient (DSC). MR-based CT were read into Eclipse Treatment Planning System (Varian Medical Systems, Palo Alto CA) and clinical Volumetric Modulated Arc Therapy (VMAT) plans were recalculated with a 0.1 cm dose calculation grid size for 10 patients. All plans were calculated with Accuros XB dose calculation algorithm for a prescription dose of 60 Gy and consisted of two arcs with a different collimator angle to minimize tongue and groove effect.
Differences between both plans were assessed according to the D2%, D98%, Dmean and γ-index (3%/3mm) for the relevant structures: CTV, PTV, brainstem and optical system. Results: MR-based CTs were generated for 10 patients using SPM software and current clinical MR examinations without the need of adding extra sequences to the clinical protocol. Bone segmentation exhibited an average DSC of 0.81±0.07 (SD) between clinical CT and MR-based CT segmentation, detecting SPM software less bone than in the clinical CT. Recalculated VMAT plans on the MR-based CTs exhibited a very good agreement with the clinical plans. Average Dmean, D2% and D98% for CTV and PTV differed less than 0.5%. Difference in D2% for brainstem and optical system between the clinical plans and recalculated plans using an MR-based CT were 0.4% and 1.1%, respectively. All metrics were found not significantly different (p>0.05) from the clinically approved plans. 3D-dose distributions for the CTV and PTV in MR-based plans resulted in γ-passing rates higher than 0.99±0.01 for both structures. Average γ-value for CTV and PTV was 0.16±0.08 and 0.23±0.16, respectively.
Conclusion:
MR-based CTs were generated using SPM software on 3D MR T1-weighted Inversion Recovery scans with more than 80% agreement for bone segmentation. MR-based VMAT plans exhibited a very good agreement with the clinical plans based on a standard CT as measured by the D2%, D98%, Dmean and γ-index metrics for all relevant structures. It is feasible a clinical workflow for radiation treatment planning purposes for glioma patients based only on MR without the need of CT or adding additional MR sequences to the clinical protocol for bone segmentation. Purpose or Objective: Current clinical practise in radiotherapy CT scanning of lung tumours takes into account movement due to breathing. However, the accuracy of used scan protocols is usually validated for phantoms with fairly regular movements, and the effects of breathing irregularity are unclear. Aim of this study is to establish the impact of clinically occurring irregularities on delineated treatment volumes determined using 4DCT images.
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Material and Methods:
Respiratory patterns, as recorded during CT scanning, were (anonymously) obtained for 50 lung S444 ESTRO 35 2016 ______________________________________________________________________________________________________ ca. patients treated in our institution. First, pattern statistics were compared to population data in literature to establish validity of the data used for testing. Second, patterns representing highest irregularity were selected: variance in amplitude (1), periodicity (2), and a pattern with a baseline drift (3). A periodical computer generated sinusoid (4) was used for comparison. Patterns were fed into a QUASAR™ Respiratory Motion Phantom (Modus Medical), with "lung tumour insert" (cork/polystyrene). Each pattern was scanned 5 times using a 16 slice lightspeed RT series scanner (General Electric). "Lung tumour" contours were extracted using auto segmentation of average (AVE) and MIP CT data. Contour volumes were compared using Dice coefficients (DC) and to expected volumes.
Results:
The average breathing amplitude in our patient population was 8.70± 3.0 mm. The average period was 3.99 ± 1.0 seconds per breath. Both compared well with literature values. Based on repeat CT data, DC was ≥ 0.90 for group ( 1) and (3) and (4). However, DC for group 2 ('irregular periodicity), was only 0.83, which is significantly lower (p= 0.002). Computed volumes were nearer to expected volumes using AVE CT, but using AVE CT always leads to underestimation. Volumes computed in MIP CT reconstructions cover the expected volumes better, but there is a chance of overestimation of up to 20% in volume.
Conclusion:
Even though 4D CT scanning has been around quite some time, this is one of the first studies to address the effects of clinically found breathing irregularities. The selected test data seem to be adequate for lung ca. patients, and selected types of irregularities are commonly seen by therapists operating CT scanner and linac. The study indicates that irregular respiratory patterns introduce the element of "chance" in the position and size of delineated tumour volumes, depending on amount and type of irregularity. Therefore, it is recommended to always take into account effect of breathing pattern irregularity in scanning and treatment planning for lung tumours. Since 4D imaging typically consists of scanning while tracking a marker position, the recommendation probably holds for every CT scanner used in radiotherapy, and possibly also for PET and MRI scanners. 
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Purpose or Objective: Most institutes use the ITV approach to account for breathing motion into treatment planning, generally yielding too large treatment volumes. Recent publications showed that use of a mid-ventilation CT (midV-CT, representing the mean breathing phase) and treating remaining breathing motions as a random error, led to high tumor control and overall survival for hypo-fractionated treatments. However, the midV-CT is not available commercially yet. In this work we perform a marker-based validation of our open-source software to generate a midV-CT for upper abdomen cancer patients.
Material and Methods:
Planning data from 12 upper abdominal cancer patients (8 liver-and 4 pancreatic patients) were used for this study. These patients were treated with the ITV approach using hypo-fractionated schemes (ranging from 5x7.5 Gy to 1x24 Gy). Each patient had a gold marker implanted close to the CTV center of mass (COM). 4DCT data consisted of 10 amplitude-based breathing phases (CT BrillianceTM, Phillips). In our planning system (EclipseTM,Varian), the position of the marker was measured by hand for each breathing phase and patient. In the opensource medical imaging 3DSlicer, B-spline deformable registration was used to register the plan CT and the different phases of the 4DCT. The resulting transformation matrices were then used by our 3DSlicer modules to automatically generate the midV-CT and the COM motions of any planning volume or marker. Subsequently, the marker position in the midV-CT was compared to the average marker position in Eclipse. Furthermore, the Eclipse marker motion curves and amplitudes were compared with the marker and CTV motions from 3DSlicer. Additionally, treatments plans were generated for one patient using the midV-CT and compared with our ITV-based clinical plan.
Results:
The mean CTV volume was 24.7±22.0 cc (1SD) and the mean marker to CTV COM distance was 12.7±6.2mm (1SD). The midV CTs are generated by 3DSlicer within 30 minutes using a PC. Motion validation results are shown in Table 1 . Differences in the mean COM of the marker in Eclipse and in midV-CT are within 1 mm, indicating an accurate midV-CT generation by our software. Average amplitude differences are within 1 mm but Eclipse motions tend to be slightly larger, possibly due to the uncertainty of manually finding the marker in the 4D phases. Correspondingly, RMS differences between motion curves of Eclipse and 3DSlicer were therefore 0.2-0.6 mm, whereas the RMS differences between marker and CTV motion in 3DSlicer only 0.1-0.2 mm (Fig 1a) . The latter suggests that wellplaced markers can estimate CTV motions. Fig 1b shows differences in dose volume histograms between the ITV and the midV-CT approach.
